Medinose Hayfever Treatment
Medinose Hayfever Treatment

Please select quantity:

Medinose heralds a breakthrough in the way hayfever and allergies are treated. Using photo therapy (light therapy) medinose can practically eliminate allergic symptoms such as congestion, runny nose, watery eyes, and headaches within a couple of weeks of use.

Please note: We are an official UK distributor of Medinose. It has come to our attention that several non genuine copies has began to appear on the market, especially through the internet. To ensure you recieve a genuine device please purchase through this website. we supply the new Medinose Plus version


To read national newspaper and television reviews on Medinose please click here.

Using photo therapy, Medinose inhibits the release of histamine, relieving or even completely eliminating allergic reactions and complaints in a natural way. The body is not burdened by drugs and Medinose has no side effects. Medinose consists of a small power pack (about the size of cigarette packet) and two probes which are inserted into the nostrils.

Each treatment session with the Medinose takes just approx. 4.5 minutes 2-3 times a day. The Medinose can be used anywhere: at home, on the move or at work. With severe symptoms, treatment can be repeated several times without any side effects. As soon as the symptoms subside, the number of treatments can be reduced. The Medinose is, however, also suitable for prevention.

Photo therapy is a method developed in hospitals for treating allergic reactions. It uses visible red light that acts on the cellular metabolism, slowing down the immune reaction and reducing inflammation of the nasal mucous membranes. The light causes an overall reduction in allergic reactions and symptoms. The manufacturers of Medinose have taken this technology and developed a hand held, consumer friendly device.




A double blind, placebo controlled trial was conducted to assess the effectiveness of Medinose. Following treatment, 72% of allergic rhinitis patients reported a reduction in symptoms and an improvement in their overall condition, compared to only 24% in the placebo group. Patients also received a nasendoscopy (examination of nasal tissue using an endoscope), which further supports the results by showing a significant reduction in nasal tissue inflammation after treatment.





Click for further product information...
Health Innovations Ltd. Terms & Conditions
Registered in England & Wales. Company Number 4926042
Website designed by Version